-
Carb-X Funds Vaccine Against Resistant Staph Infections
An international consortium is funding a vaccine to prevent increasingly resistant Staphylococcus aureus infections found in health care facilities.
-
Multiple Solid-Tumor Immunotherapy Trial Underway
A clinical trial is underway testing an immunotherapy for several types of stubborn solid tumor cancer, based on research in university labs.
-
Tools to Game Effectively on Apple Devices
Here are four tools Apple fans will require to game effectively.
-
Microbe Therapy Maker Expands, Adds Venture Funds
A company providing manufacturing services for microbiome drug developers is expanding its facilities, with an infusion of new venture funds.
-
FDA Authorizes Non-Prescription Covid-19 Test
Food and Drug Administration granted an emergency authorization for a molecular test for SARS-CoV-2 viruses done at home without a prescription.
-
Two Therapies Dropped from NIH Covid-19 Trial
A clinical trial testing multiple treatments for people hospitalized with Covid-19 infections is dropping two therapies for not meeting efficacy standards.
-
Crispr Enables Inhaled Flu, Covid-19 Treatment
A biomedical engineering lab designed and tested in lab animals gene-edited therapies for influenza and Covid-19, inhaled by patients with a home device.
-
Small Biz Grant Funds Hibernating Animal Drug Discovery
A company identifying drug targets from genetic processes in hibernating animals is receiving an NIH grant to advance its technology for heart disease.
-
Mental Health Requests Rise During Pandemic
An analysis of health records shows requests for mental health services increased markedly during the early months of the Covid-19 pandemic.
-
Sensor in Works Detecting Covid-19 Airborne Virus
A company developing graphene bio-computer chips is applying its technology to sensors that quickly detect SARS-CoV-2 viruses in indoor air.